Fig. 4
From: Effects of peptides derived from active sites of visfatin on wound healing
Angiogenic activity of Vis-1 on subcutaneous wound tissues. Representative images of the newly formed blood vessels at the wound area (A) on day 10 post-injury in the mice treated with control (DPBS), positive control (hEGF), 1 µM and 20 µM of Vis-1 peptide. Quantification of vessel area (B), number of junctions (C), and number of endpoints (D) from the images using AngioTool. Data are expressed as a mean ± SEM. *p < 0.05, **p < 0.01 and ***p < 0.001 (vs. control). hEGF human epidermal growth factor, Vis-1 visfatin-derived peptide-1.
